Skip to main content
. 2018 Jan 21;8(1):e018184. doi: 10.1136/bmjopen-2017-018184

Figure 2.

Figure 2

Time trends in the proportions of patients prescribed (A) acetylsalicylic acid monotherapy, (B) clopidogrel monotherapy, (C) dual antiplatelet therapy, (D) an ACE inhibitor or an angiotensin receptor blocker, (E) a statin, or (F) combined therapy with an antiplatelet, plus an ACE inhibitor or an angiotensin receptor blocker, plus a statin in the 12 months before and 12 months after an incident diagnosis of PAD. Shaded area highlights the 2 months before and 2 months after the PAD diagnosis. PAD, peripheral artery disease.